240 related articles for article (PubMed ID: 22289436)
1. Liposomes for intravitreal drug delivery: a state of the art.
Bochot A; Fattal E
J Control Release; 2012 Jul; 161(2):628-34. PubMed ID: 22289436
[TBL] [Abstract][Full Text] [Related]
2. [Potential of liposomes for the intravitreal injection of therapeutic molecules].
Bochot A; Lajavardi L; Camelo S; Bourges JL; Behar-Cohen F; de Kozak Y; Fattal E
Ann Pharm Fr; 2011 Mar; 69(2):100-7. PubMed ID: 21440102
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery to the posterior segment of the eye.
Thrimawithana TR; Young S; Bunt CR; Green C; Alany RG
Drug Discov Today; 2011 Mar; 16(5-6):270-7. PubMed ID: 21167306
[TBL] [Abstract][Full Text] [Related]
4. Determination and pharmacokinetic profile of liposomal foscarnet in rabbit ocular tissues after intravitreal administration.
Claro C; Ruiz R; Cordero E; Pastor MT; López-Cortés LF; Jiménez-Castellanos M; Lucero M
Exp Eye Res; 2009 Mar; 88(3):528-34. PubMed ID: 19084004
[TBL] [Abstract][Full Text] [Related]
5. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
Myles ME; Neumann DM; Hill JM
Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
[TBL] [Abstract][Full Text] [Related]
6. Novel drug delivery systems for retinal diseases. A review.
Lee SS; Robinson MR
Ophthalmic Res; 2009; 41(3):124-35. PubMed ID: 19321933
[TBL] [Abstract][Full Text] [Related]
7. Nanotherapy for posterior eye diseases.
Kaur IP; Kakkar S
J Control Release; 2014 Nov; 193():100-12. PubMed ID: 24862316
[TBL] [Abstract][Full Text] [Related]
8. [The use of liposomes as intravitreal drug delivery system].
Bejjani RA; Jeanny JC; Bochot A; Behar-Cohen F
J Fr Ophtalmol; 2003 Nov; 26(9):981-5. PubMed ID: 14631286
[TBL] [Abstract][Full Text] [Related]
9. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug.
Cheng L; Hostetler KY; Gardner MF; Avila CP; Bergeron-Lynn G; Keefe KS; Wiley CA; Freeman WR
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1487-95. PubMed ID: 10359331
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal delivery of oligonucleotides by sterically stabilized liposomes.
Bochot A; Fattal E; Boutet V; Deverre JR; Jeanny JC; Chacun H; Couvreur P
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):253-9. PubMed ID: 11773039
[TBL] [Abstract][Full Text] [Related]
12. Drainage of fluorescent liposomes from the vitreous to cervical lymph nodes via conjunctival lymphatics.
Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Fattal E; Behar-Cohen F; de Kozak Y
Ophthalmic Res; 2008; 40(3-4):145-50. PubMed ID: 18421229
[TBL] [Abstract][Full Text] [Related]
13. Medical devices for the treatment of eye diseases.
Yasukawa T; Ogura Y
Handb Exp Pharmacol; 2010; (197):469-89. PubMed ID: 20217540
[TBL] [Abstract][Full Text] [Related]
14. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
[TBL] [Abstract][Full Text] [Related]
15. Treatment of experimental autoimmune uveoretinitis with intravitreal injection of tacrolimus (FK506) encapsulated in liposomes.
Zhang R; He R; Qian J; Guo J; Xue K; Yuan YF
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3575-82. PubMed ID: 20164461
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone acetonide: a change in a paradigm.
Jonas JB
Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
[TBL] [Abstract][Full Text] [Related]
17. Periocular routes for retinal drug delivery.
Raghava S; Hammond M; Kompella UB
Expert Opin Drug Deliv; 2004 Nov; 1(1):99-114. PubMed ID: 16296723
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of endotoxin-induced uveitis by intravitreal injection of vasoactive intestinal Peptide encapsulated in liposomes.
Lajavardi L; Bochot A; Camelo S; Goldenberg B; Naud MC; Behar-Cohen F; Fattal E; de Kozak Y
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3230-8. PubMed ID: 17591893
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.
Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672
[TBL] [Abstract][Full Text] [Related]
20. Gel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids.
Fattal E; De Rosa G; Bochot A
Int J Pharm; 2004 Jun; 277(1-2):25-30. PubMed ID: 15158966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]